Clinical Trials
CureVac’s COVID-19 Vaccine Demonstrated Efficient Protection of Non-Human Primates...
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced the publication of preclinical data...
Packaging & Labelling
DHL Express plays vital role in European Covid-19 vaccine...
Since Christmas, DHL Express, the worldwide leading express service provider, has operated more than 50 flights transporting numerous shipments of the urgently needed COVID-19 vaccines...
Drug Research
Baxter BioPharma Solutions Announces Sterile Manufacturing Agreement for Novavax...
Baxter International Inc., a global leader in sterile medication production and delivery, announced that Baxter BioPharma Solutions has entered into an agreement to provide sterile...
Press Releases
Approvals of COVID-19 biologics will put huge pressure on...
The third part of the 2020 CPhI Annual Report – released during the second week of the CPhI Festival of Pharma (5-16 October, 2020) –...
News
After Sputnik V, Russia grants approval to 2nd COVID-19...
Russia announced that it has granted regulatory approval to another Covid-19 vaccine named EpiVacCorona. This comes after the country granted similar approval to Sputnik V,...
Press Releases
Thermo Fisher Scientific Further Expands COVID-19 Test Portfolio with...
Thermo Fisher Scientific Inc., the world leader in serving science, introduced two new SARS-CoV-2 antibody tests: the Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test,...
Clinical Trials
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical...
Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.